Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

Author： Hou Ya-Chin   Chao Ying-Jui   Tung Hui-Ling   Wang Hao-Chen   Shan Yan-Shen  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|17|2766-2777

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.17, 2014-09, pp. : 2766-2777

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CD133 as a target for colon cancer

By Catalano Veronica   Di Franco Simone   Iovino Flora   Dieli Francesco   Stassi Giorgio   Todaro Matilde  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Targeting CD133 antigen in cancer

By Ferrandina Gabriella   Petrillo Marco   Bonanno Giuseppina   Scambia Giovanni  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 823-837

Informa Healthcare

Access to resources Recommend Favorite

SGN-30: a basis for the effective treatment of CD30 positive hematopoietic malignancies

By Pinter-Brown Lauren C  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1883-1887

Informa Healthcare

Access to resources Recommend Favorite

CD20-positive T-cell Lymphoma with Indolent Clinical Behaviour

By Xiao W-B   Wang Z-M   Wang L-J  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1170-1174

Field House Publishing

Access to resources Recommend Favorite

Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines

By  

Current Cancer Drug Targets, Vol. 14, Iss. 9, 2014-11 ,pp. : 832-849

Bentham Science Publishers

Access to resources Recommend Favorite